Abstract:Metabolic changes during kidney and liver disease can induce increased production of oxygen radicals that play an important role in the progression of kidney and liver damage and in the appearance of important comorbidities. In the study reported here, the effect of alpha-lipoic acid (ALA) on the chemiluminescence (CL) and TBARS determination of microsomes isolated from rat kidney and liver was analyzed. Oxidative stress in microsomes was induced by subjecting samples (1 mg of protein) to an ascorbate-Fe++-dependent (0.4 mM)-Fe++ (2.15 μM) prooxidant system at 37 °C for 120 min. Oxidative damage was quantified by two methods, TBARS and CL: CL was determined using a Packard 1900 TR liquid scintillation counter (Meriden CT, USA). CL was expressed as cpm (counts per minute) was read every 10 minutes to establish the course of peroxidation as a function of time. Likewise, the total value of cpm (sum of the readings) was used to compare the inhibitory effect of ALA using different concentrations corresponding to 0.05; 0.15 and 0.25 μg of ALA per mg of microsomal protein. Controls were run simultaneously without the addition of ascorbate-Fe++. It was observed that the CL was lower in the kidney and liver microsomes obtained from the ALA group than in the control group (without ALA). In addition, -ALA was found to be concentration-dependent (0.05, 0.15 and 0.25 μg of ALA per mg of solution) reduced in CL, measured as total cpm. After that it was done the determination of lipid peroxidation products (Thiobarbituric Acid Reactive Substances—TBARS). TBARS were measured in the microsomal samples. Lipoperoxidation inhibition depended on the concentration of ALA in the incubation mixture. The results show that for all the concentrations tested, a protective effect on the induced oxidative damage was found. CL and TBARS level analyzes indicate that ALA may act as an antioxidant protecting rat kidney and liver microsomes from lipoperoxidative damage.

(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease

(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis

(+)Alpha-Lipoic Acid Regulates Lipid Metabolism Gene Expression and Lipidic Profile in a Cellular Model of Fatty Acid Overload

α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats

Impact of dietary lipoic acid supplementation on liver mitochondrial bioenergetics and oxidative status on normally fed Wistar rats

Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease

Alpha-lipoic Acid Improves High-Fat Diet-Induced Hepatic Steatosis by Modulating the Transcription Factors SREBP-1, FoxO1 and Nrf2 Via the SIRT1/LKB1/AMPK Pathway.

(R)-α-Lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate

Alpha-lipoic acid supplementation increases the efficacy of exercise- and diet-induced obesity treatment and induces immunometabolic changes in female mice and women

Alpha-lipoic Acid Attenuates Endoplasmic Reticulum Stress-Induced Insulin Resistance by Improving Mitochondrial Function in HepG2 Cells

N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function

Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety

Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice

Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway

Omega-3 Polyunsaturated Fatty Acids: A Specific Liver Drug for Non-Alcoholic Fatty Liver Disease (NAFLD)

Effect of alpha-lipoic acid on rat kidney and liver microsomes subjected to oxidative stress induced by ascorbate-Fe++

Eliciting the Mitochondrial Unfolded Protein Response by Nicotinamide Adenine Dinucleotide Repletion Reverses Fatty Liver Disease in Mice

Alpha-Lipoic Acid: Antioxidant Activity Against Non-Enzymatic Peroxidation of Rat Kidney and Liver Mitochondria

Active Vitamin D Supplementation Alleviates Initiation and Progression of Nonalcoholic Fatty Liver Disease by Repressing the P53 Pathway.

Synergistic effects of punicic acid and alpha lipoic acid ameliorate inflammatory and metabolic genes expression in C2C12 myoblast cells under oxidative stress condition

Α-Lipoic Acid Alleviates Hepatic Lipid Deposition by Inhibiting FASN Expression Via Mir-3548 in Rats